Publications
39
Citations
1,097
Est. group size
—
Recurring co-author estimate
Active years
46
Publishing since 1980
Typically publishes in teams of ~12 · 17% small-team papers (≤3 authors) · across 5 venues
- An 18-year Odyssey: navigating the complex path of prolactinoma management: a case report
Cardiovascular Diabetology – Endocrinology Reports · 2025
- Long-acting pasireotide improves clinical signs and quality of life in Cushing’s disease: results from a phase III study
Journal of Endocrinological Investigation · 2020
- Gigantism due to two different causes in the same family - AIP mutation-positive acromegaly and Marfan syndrome
Endocrine Abstracts · 2018
- Monthly pasireotide provides clinical benefit over 12 months in patients with Cushing's disease
Endocrine Abstracts · 2017
- Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial
The Lancet Diabetes & Endocrinology · 2017
- Increased Population Risk of<i>AIP</i>-Related Acromegaly and Gigantism in Ireland
Human Mutation · 2016
- Journal of Neurological Surgery Part B Skull Base×4
- Endocrine Abstracts×2
- The Lancet Diabetes & Endocrinology×1
- The Journal of Clinical Endocrinology & Metabolism×1
- Journal of Endocrinological Investigation×1
- Diane Donegan
Medicine · Indiana University
- Luma Ghalib
Medicine · The Ohio State University
- Feng Gu
Medicine · University of Michigan
- Robert Murray
Medicine · The Ohio State University
- Jorge Portugal
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile